By Sheri Kasprzak
New York, Dec. 12 - MIV Therapeutics, Inc. settled a private placement with foreign investors for $1 million.
The company issued 2 million units of one share and one warrant. Each warrant is exercisable at $0.75 for two years.
The offering was not brokered.
Based in Atlanta, MIV produces biocompatible coatings used in cardiovascular stents and other implanted medical devices.
| Issuer: | MIV Therapeutics, Inc.
|
| Issue: | Units of one share and one warrant
|
| Amount: | $1 million
|
| Units: | 2 million
|
| Price: | $0.50
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | $0.75
|
| Placement agent: | Non-brokered
|
| Settlement date: | Nov. 8
|
| Stock symbol: | OTCBB: MIVT
|
| Stock price: | $0.44 at close Nov. 8
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
